Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel

By afschroeder • August 21, 2025

Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen NJ, Shaukat A, Sirlin CB, Verna E, Wani S, Wilson Woods A, Yang JD, Parikh ND. Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology. 2025 Sep 1;82(3):794-809. doi: 10.1097/HEP.0000000000001203. Epub 2024 Dec 18. PMID: 40833999.

Tags: Biomarker, Cedars Sinai DoM, Cirrhosis, Digestive Diseases, liver cancer, Publications, screening, ultrasound

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

Nassar AH, Kim C, Adeyelu T, Bou Farhat E, Abushukair H, Rakaee M, Matteson K, Lau SF, Takabe Y, Ocejo A, Ardeshir-Larijani F, Leal T,[...]

Accelerated 3D qCEST of the Spine in a Porcine Model Using MR Multitasking at 3T

Cheema K, De Righi DR, Shen C, Lee HL, Kaneda G, Wechsler J, Chavez M, Avalos P, Floyd C, Tawackoli W, Xie Y, Christodoulou AG,[...]

The evolving risk of infective endocarditis after transcatheter aortic valve implantation

Alabbadi SH, Iribarne A, Rodés-Cabau J, Doenst T, Chikwe J, Itagaki S, Toyoda N, Makkar R, Akowuah EF, Perez M, Bandettini WP, Akhter SA, Bleiziffer[...]